Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Kiniksa Pharmaceuticals International, plc KNSA

Healthcare  —  Drug Manufacturers Specialty & Generic
75.08 (0.26) (0.35%) as of 25 Sep
Market cap
$5.9B
P/E
70.2×
Cash Flow Champion (5y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending)
Download Excel — free account

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Cash and Short Term Investments

+8 more quarters

 352.10 414.07 468.09 525.93
Receivables 51.74 15.59 23.22 23.49
Inventory 41.40 54.90 73.14 70.93
Total current assets 475.53 527.18 594.17 668.63
Property, Plant, Equpment (Net) 1.66 1.94 1.99 2.58
Goodwill and Intangible Assets (Total) 15.50 15.25 15.00 14.75
Long Term Assets (Tax, Deferred) 201.29 198.15 193.63 190.97
Long-term assets (Other) 8.29 11.31 11.16 10.83
Total non-current assets 236.80 236.46 231.11 227.48
Total Assets 712.33 763.63 825.28 896.11
Accounts Payable 6.15 2.03 24.40 12.40
Accrued Expenses 94.22 112.04 108.35 134.78
Other current liabilities 20.52 22.13 20.69 20.05
Total current liabilities 123.59 139.18 156.61 171.25
Non-current Revenue (Deferred) 31.81 31.81 31.81 31.81
Non-current Liabilities (Other) 14.53 18.52 25.32 34.02
Total non-current liabilities 53.36 56.84 62.98 70.71
Total liabilities 176.95 196.03 219.59 241.96
Additional Paid In Capital 1,011.85 1,029.75 1,045.88 1,069.62
Common Stock (Net) 0.02 0.02 0.02 0.02
Retained Earnings (476.34) (462.14) (439.55) (414.11)
Common Equity (Total) 535.38 567.61 605.69 654.15
Shareholders Equity (Total) 535.38 567.61 605.69 654.15
Shareholders Equity and Liabilities (Total) 712.33 763.63 825.28 896.11
Shares (Common) 75.43 76.29 76.69 77.98
Shareholders Equity (Tangible) 519.88 552.36 590.69 639.40
Net Debt (352.10) (414.07) (468.09) (525.93)

Fold the line items

In millions of $ except per-share values · columns are period end dates